Drug-related overdose deaths among teens more than doubled between 2019 and 2020, despite adolescent drug use becoming less common. Teen overdoses have reached a crisis point, a new study published in the New England Journal of Medicine found, with an average of 22 adolescents dying from drug overdoses every week in 2022. Fentanyl is among […]
Stephanie Strong founded Boulder Care in 2017 with an ambitious goal: build a profitable substance use disorder (SUD) treatment business that would also accept Medicaid patients, many caught up in the opioid epidemic. Strong’s timing proved auspicious. Over a year later, a new federal law came into effect requiring states to cover federally approved opioid […]
Medications like methadone and buprenorphine have become the gold standard for treating opioid use disorder (OUD). But many people with OUD still receive abstinence-based treatment or no treatment at all for the chronic disorder. And people with OUD who receive abstinence-only treatment are more likely to die than people who receive no treatment at all, […]
November is fast approaching, and with it comes the Drug Enforcement Administration’s (DEA) proposed rule on telehealth and controlled substance prescribing. After a six-month delay, the federal law enforcement and regulatory body will release regulations that will shape the future of telehealth within behavioral health in the post-COVID era. It also has the potential to […]
Within the behavioral health sector, it has been a bumpy 12 months for autism treatment providers. But it’s turning out to be somewhat of a tumultuous year for those in the substance use disorder (SUD) space as well. SUD dealmaking fell below pre-pandemic levels in Q1, according to a recent report by M&A advisory firm […]
The Drug Enforcement Administration (DEA) released a temporary rule extending COVID-era telehealth flexibilities from the end of the public health emergency (PHE) on May 11 to Nov. 11, 2023. The extension allows clinicians prescribing controlled substances over telehealth to continue to do so for another six months. Patients that initiate care on or before Nov. […]
The proposed telehealth-prescribing rules from the Drug Enforcement Administration (DEA) could require digital addiction providers to fundamentally change their business model and limit patient access to virtual addiction treatment. These new rules will likely hit patients with the least access to status quo treatment models the hardest, especially for access to medication-assisted treatment (MAT). “Roughly […]
The new telehealth restrictions proposed by the Drug Enforcement Administration (DEA) last week struck a sour chord with several industry stakeholders. Many industry insiders condemned the move as out of touch and even dangerous, jeopardizing telehealth models’ effectiveness in behavioral health. Still, the proposal is not set in stone, and parts of it could change […]
In the two weeks after leaving incarceration, individuals are 40 times more likely to die from an opioid overdose than the general public. Yet, for years, there has been little attention paid to treating substance use disorders (SUD) in prisons and when individuals are reintroduced into society. But this could improve as providers team up […]
The growing demand for substance use disorder (SUD) services and the fragmented nature of the industry has made it prime for consolidation. Potential buyers prioritize reputation, quality and the ability to expand their geographical reach. Meanwhile, sellers want a transaction that keeps the integrity of their business intact, according to panelists at Behavioral Health Business’ […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
